1 |
Whitney, N. P., Eidem, T. M., Peng, H., Huang, Y. and Zheng, J. C. 2009. Inflammation mediates varying effects in neurogenesis: Relevance to the pathogenesis of brain injury and neurodegenerative disorders. J. Neurochem. 108, 1343-1359.
DOI
|
2 |
Zecca, L., Wilms, H., Geick, S., Claasen, J. H., Brandenburg, L. O. and Holzknecht, C. 2008. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson’s disease. Acta Neuropathol. 116, 47-55.
DOI
|
3 |
Wilms, H., Rosenstiel, P., Sievers, J., Deuschl, G., Zecca, L. and Lucius, R. 2003. Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson’s disease. FASEB J. 17, 500-507.
|
4 |
Collin, M., McGovern, N. and Haniffa, M. 2013. Human dendritic cell subsets. Immunology 140, 22-30.
DOI
|
5 |
Colton, C. A. 2009. Heterogeneity of microglial activation in the innate immune response in the brain. J. Neuroimmune Pharmacol. 4, 399-418.
DOI
|
6 |
Gonzalez, H., Elgueta, D., Montoya, A. and Pacheco, R. 2014. Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases. J. Neuroimmunol. 274, 1-13.
DOI
|
7 |
Kamon, M., Zhao, R. and Sakamoto, K. 2010. Green tea polyphenol (−)-epigallocatechin gallate suppressed the differentiation of murine osteoblastic MC3T3-E1 cells. Cell Biol. Int. 34, 109-416.
|
8 |
Khandelwal, P. J., Herman, A. M. and Moussa, C. E. 2011. Inflammation in the early stages of neurodegenerative pathology. J. Neuroimmunol. 238, 1-11.
DOI
|
9 |
Li, Y., Du, X. F., Liu, C. S., Wen, Z. L. and Du, J. L. 2012. Reciprocal regulation between resting microglial dynamics and neuronal activity in vivo. Dev. Cell 23, 1189-1202.
DOI
|
10 |
Fuhrmann, M., Bittner, T., Jung, C. K., Burgold, S., Page, RM., Mitteregger, G., Haass, C., LaFerla, F. M., Kretzschmar, H. and Herms, J. 2010. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer’s disease. Nat. Neurosci. 13, 411-413.
DOI
|
11 |
Hirsch, E. C. and Hunot, S. 2009. Neuroinflammation in Parkinson’s disease: a target for neuroprotection? Lancet Neurol. 8, 382-387.
DOI
|
12 |
Maetzler, W., Apel, A., Langkamp, M., Deuschle, C., Dilger, S. S. and Stirnkorb, J. G., 2014. Comparable auto antibody serum levels against amyloid-and inflammation-associated proteins In Parkinson’s disease patients and controls. PLoS One 9, 88604.
DOI
|
13 |
Beutler, B., Du, X. and Poltorak A. 2001. Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies. J. Endotoxin Res. 7, 277-280.
DOI
|
14 |
Takeuchi, H., Mizoguchi, H., Doi, Y., Jin, S., Noda, M., Liang, J., Li, H., Zhou, Y., Mori, R., Yasuoka, S., Li, E., Parajuli, B., Kawanokuchi, J., Sonobe, Y., Sato, J., Yamanaka, K., Sobue, G., Mizuno, T. and Suzumura, A. 2011. Blockade of gap junction hemichanel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer’s disease. PLoS One 6, 21108.
DOI
|
15 |
Seija, L. 2010. Innate immunity and neuroinflammation in the CNS: The role of microglia in toll-like receptor- mediated neuronal injury. GLIA 58, 253-263.
|
16 |
Shenouda, S. M. and Vita, J. A. 2007. Effects of flavonoidcontaining beverages and EGCG on endothelial function. J. Am. Coll. Nutr. 26, 366-372.
DOI
|
17 |
Singh, B. N., Shankar, S. and Srivastava, R. K. 2010. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem. Pharmacol. 82, 1807-1821.
|
18 |
Clement, Y. 2009. Can green tea do that? A literature review of the clinical evidence. Prev. Med. 49, 83-87.
DOI
|
19 |
Chen, Z., Jalabi, W., Shpargel, K. B., Farabaugh, K.T., Dutta, R., Yin, X., Kidd, G. J., Bergmann, C. C., Stohlman, S. A. and Trapp, B. D. 2012. Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J. Neurosci. 32, 11706-11715.
DOI
|